Biome Australia Ltd (AU:BIO) has released an update.
Biome Australia Ltd has announced the release of its Vision 27 strategic plan, charting the company’s growth objectives from FY25 to FY27, including revenue targets, distribution, international expansion, and new product development. The company, known for its clinically-supported probiotics and complementary medicines, invites stakeholders to view a detailed video presentation of Vision 27 by Managing Director Blair Vega Norfolk. This roadmap is set to steer Biome’s innovative health solutions through strategic enhancements and market expansion over the next three years.
For further insights into AU:BIO stock, check out TipRanks’ Stock Analysis page.